找不到产品?留下需求帮您找
一键询价UPCISCC090 人舌头鳞癌细胞 QCH766
一周
3500¥
KNS62 人肺支气管鳞状细胞癌 QCH767
一周
3500¥
HCC95 人肺腺癌细胞 QCH768
一周
3500¥
HARA 人肺腺癌细胞 QCH769
一周
3500¥
EPLC272H 人肺腺癌细胞 QCH770
一周
4000¥
NCI-H810 人非小细胞肺癌细胞 QCH771
一周
5000¥
HBL-1 人弥漫性大B细胞淋巴瘤 QCH772
一周
1800¥
FTC238 人滤泡状甲状腺癌细胞,肺转移 XY-H773
一周
3500¥
SNU-719 人胃癌细胞 QCH774
一周
3500¥
BT549+GFP+LUC 人乳腺癌细胞 QCH766GL
钦诚生物 | 一周
4500¥
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:(R)-BPO-27 产品别名:见爱必信官网 英文别名:(R)-BPO-27 靶点:CFTR CAS:1415390-47-4 纯度: 外观:见爱必信官网 保存方法: 描述:(R)-BPO-27 is a potent CFTR inhibitor with an IC50 of 4 nM. 溶解性:DMSO 体外研究: The benzopyrimido-pyrrolo-oxazinedione BPO-27 is an analogue of PPQ-102, which inhibits CFTR with an IC50 of 8 nM. The R enantiomer of BPO-27 inhibits CFTR chloride conductance with an IC50 of 4 nM, while S enantiomer is inactive. In vitro metabolic stability in hepatic microsomes shows both enantiomers as stable, with less than 5% metabolism in 4 h. (R)-BPO-27 binds near the canonical ATP binding site. Whole-cell patch-clamp studies shows linear CFTR currents with a voltage-independent (R)-BPO-27 block mechanism. At a concentration of (R)-BPO-27 that inhibits CFTR chloride current by 50%, the EC50 for ATP activation of CFTR increases from 0.27 to 1.77 mM. 体内研究:Following bolus interperitoneal administration in mice, serum (R)-1 decays with t1/2 ≈ 1.6 h and gives sustained therapeutic concentrations in kidney.
产品信息订购:
|